Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C
- Author
- WEDEMEYER, Heiner1 ; SCHULLER, Elisabeth2 ; HOFMANN, Wolf P7 ; HINRICHSEN, Holger8 ; TAUBER, Erich2 ; MANNS, Michael P1 ; KLADE, Christoph S2 ; SCHLAPHOFF, Verena1 ; STAUBER, Rudolf E3 ; WIEGAND, Johannes4 ; SCHIEFKE, Ingolf4 ; FIRBAS, Christa5 ; JILMA, Bernd5 ; THURSZ, Mark6 ; ZEUZEM, Stefan7
[1] Department of Gastroenterology, Hepatology, and Endocrinology, Medical University of Hannover, Hannover, Germany
[2] Intercell AG, Campus Vienna Biocenter 3, 1030 Vienna, Austria
[3] Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University ofGraz, Graz, Austria
[4] Department of Medicine II, University of Leipzig, Leipzig, Germany
[5] Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
[6] Gastroenterology and Hepatology Research, Imperial College St Mary's Hospital Campus, London, United Kingdom
[7] Department of Internal Medicine II, Saarland University Hospital, Homburg/Saar, Germany
[8] Department of Medicine, Christian-Albrechts- University, Kiel, Germany - Source
Vaccine. 2009, Vol 27, Num 37, pp 5142-5151, 10 p ; ref : 49 ref
- Publisher
- Elsevier, Kidlington
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- Hepatitis C virus IC41 Sustained virologic response
- Keyword (fr)
- Homme Hépatite virale C Immunothérapie Norme Traitement Virus hépatite C Flaviviridae Hepacivirus Infection Pathologie de l'appareil digestif Pathologie du foie Virose Virus
- Keyword (en)
- Human Viral hepatitis C Immunotherapy Standards Treatment Hepatitis C virus Flaviviridae Hepacivirus Infection Digestive diseases Hepatic disease Viral disease Virus
- Keyword (es)
- Hombre Hepatítis virica C Inmunoterapia Norma Tratamiento Hepatitis C virus Flaviviridae Hepacivirus Infección Aparato digestivo patología Hígado patología Virosis Virus
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A05 Microbiology / 002A05C Virology / 002A05C10 Miscellaneous
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A05 Microbiology / 002A05F Applied microbiology / 002A05F04 Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02G Viral hepatitis
- Discipline
- Infectious pathology Microbiology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 21792484
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.vaccine.2009.06.027 
https://dx.doi.org/10.1016/j.vaccine.2009.06.027
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2009.06.027\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:2:\"37\";s:8:\"\u0000*\u0000spage\";s:4:\"5142\";s:8:\"\u0000*\u0000epage\";s:4:\"5151\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"WEDEMEYER\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Heiner\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:19:\"SCHULLER, Elisabeth\";i:1;s:15:\"HOFMANN, Wolf P\";i:2;s:18:\"HINRICHSEN, Holger\";i:3;s:13:\"TAUBER, Erich\";i:4;s:16:\"MANNS, Michael P\";i:5;s:18:\"KLADE, Christoph S\";i:6;s:18:\"SCHLAPHOFF, Verena\";i:7;s:17:\"STAUBER, Rudolf E\";i:8;s:17:\"WIEGAND, Johannes\";i:9;s:16:\"SCHIEFKE, Ingolf\";i:10;s:15:\"FIRBAS, Christa\";i:11;s:12:\"JILMA, Bernd\";i:12;s:12:\"THURSZ, Mark\";i:13;s:14:\"ZEUZEM, Stefan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2009.06.027\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:2:\"37\";s:8:\"\u0000*\u0000spage\";s:4:\"5142\";s:8:\"\u0000*\u0000epage\";s:4:\"5151\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"WEDEMEYER\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Heiner\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:19:\"SCHULLER, Elisabeth\";i:1;s:15:\"HOFMANN, Wolf P\";i:2;s:18:\"HINRICHSEN, Holger\";i:3;s:13:\"TAUBER, Erich\";i:4;s:16:\"MANNS, Michael P\";i:5;s:18:\"KLADE, Christoph S\";i:6;s:18:\"SCHLAPHOFF, Verena\";i:7;s:17:\"STAUBER, Rudolf E\";i:8;s:17:\"WIEGAND, Johannes\";i:9;s:16:\"SCHIEFKE, Ingolf\";i:10;s:15:\"FIRBAS, Christa\";i:11;s:12:\"JILMA, Bernd\";i:12;s:12:\"THURSZ, Mark\";i:13;s:14:\"ZEUZEM, Stefan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2009.06.027\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2009.06.027\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:2:\"37\";s:8:\"\u0000*\u0000spage\";s:4:\"5142\";s:8:\"\u0000*\u0000epage\";s:4:\"5151\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"WEDEMEYER\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Heiner\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:19:\"SCHULLER, Elisabeth\";i:1;s:15:\"HOFMANN, Wolf P\";i:2;s:18:\"HINRICHSEN, Holger\";i:3;s:13:\"TAUBER, Erich\";i:4;s:16:\"MANNS, Michael P\";i:5;s:18:\"KLADE, Christoph S\";i:6;s:18:\"SCHLAPHOFF, Verena\";i:7;s:17:\"STAUBER, Rudolf E\";i:8;s:17:\"WIEGAND, Johannes\";i:9;s:16:\"SCHIEFKE, Ingolf\";i:10;s:15:\"FIRBAS, Christa\";i:11;s:12:\"JILMA, Bernd\";i:12;s:12:\"THURSZ, Mark\";i:13;s:14:\"ZEUZEM, Stefan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2009.06.027\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:2:\"37\";s:8:\"\u0000*\u0000spage\";s:4:\"5142\";s:8:\"\u0000*\u0000epage\";s:4:\"5151\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"WEDEMEYER\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Heiner\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:19:\"SCHULLER, Elisabeth\";i:1;s:15:\"HOFMANN, Wolf P\";i:2;s:18:\"HINRICHSEN, Holger\";i:3;s:13:\"TAUBER, Erich\";i:4;s:16:\"MANNS, Michael P\";i:5;s:18:\"KLADE, Christoph S\";i:6;s:18:\"SCHLAPHOFF, Verena\";i:7;s:17:\"STAUBER, Rudolf E\";i:8;s:17:\"WIEGAND, Johannes\";i:9;s:16:\"SCHIEFKE, Ingolf\";i:10;s:15:\"FIRBAS, Christa\";i:11;s:12:\"JILMA, Bernd\";i:12;s:12:\"THURSZ, Mark\";i:13;s:14:\"ZEUZEM, Stefan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2009.06.027\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:2:\"37\";s:8:\"\u0000*\u0000spage\";s:4:\"5142\";s:8:\"\u0000*\u0000epage\";s:4:\"5151\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"WEDEMEYER\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Heiner\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:19:\"SCHULLER, Elisabeth\";i:1;s:15:\"HOFMANN, Wolf P\";i:2;s:18:\"HINRICHSEN, Holger\";i:3;s:13:\"TAUBER, Erich\";i:4;s:16:\"MANNS, Michael P\";i:5;s:18:\"KLADE, Christoph S\";i:6;s:18:\"SCHLAPHOFF, Verena\";i:7;s:17:\"STAUBER, Rudolf E\";i:8;s:17:\"WIEGAND, Johannes\";i:9;s:16:\"SCHIEFKE, Ingolf\";i:10;s:15:\"FIRBAS, Christa\";i:11;s:12:\"JILMA, Bernd\";i:12;s:12:\"THURSZ, Mark\";i:13;s:14:\"ZEUZEM, Stefan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
